TXN logo

TXN · Texas Instruments Incorporated

Last updated Oct 29, 2026
Recommendation
HOLD
12-Month Target
$300.00
-3.2% return
Reference Price
$309.83
October 28, 2026
INSTITUTIONAL MEMORANDUM · TXN NASDAQ 100

Peak Cycle, Peak Multiple?

Earnings are accelerating, but the stock already capitalizes a near-flawless recovery and integration.

L2 Capital Institutional Verdict

Texas Instruments Incorporated (TXN) is currently rated HOLD with a 12-month valuation target of $300.00 (implied return: -3.2%). Based on forensic analysis of SEC filings and audited cash flows, High conviction reflects Q3 revenue rose 28% year over year while operating margin expanded 12.4 percentage points to 47.5%, demonstrating powerful fixed-cost leverage..

Executive Thesis

Texas Instruments is a premier analog franchise, but its valuation already discounts a powerful cyclical recovery and unusually durable growth. Rising factory utilization, 300mm economics and broad industrial, automotive and data-center demand are driving exceptional incremental margins. Reported free cash flow is materially assisted by CHIPS incentives, inventory remains elevated, dilution persists, and the pending Silicon Labs acquisition adds execution and leverage risk. Maintain a HOLD and avoid adding above $300 absent higher normalized earnings or a material valuation reset.

Key Actionable Findings

Click any finding to interrogate with Andy ↗
Q3 revenue rose 28% year over year while operating margin expanded 12.4 percentage points to 47.5%, demonstrating powerful fixed-cost leverage.
Trailing free cash flow reached $8.4 billion under TI's definition, but approximately $1.6 billion reflects direct CHIPS funding and investment-tax-credit cash benefits.
The $7.5 billion Silicon Labs transaction expands wireless connectivity but is priced near 9.6 times the target's 2025 revenue and depends on $450 million of annual synergies.

Frequently Asked Questions: TXN

What is L2 Capital's investment rating and price target for TXN?

L2 Capital currently maintains an institutional rating of HOLD on Texas Instruments Incorporated (TXN) with a 12-month target price of $300.00 (implied return: -3.2%), backed by High conviction.

What is the core investment thesis for TXN?

Texas Instruments is a premier analog franchise, but its valuation already discounts a powerful cyclical recovery and unusually durable growth. Rising factory utilization, 300mm economics and broad industrial, automotive and data-center demand are driving exceptional incremental margins. Reported free cash flow is materially assisted by CHIPS incentives, inventory remains elevated, dilution persists, and the pending Silicon Labs acquisition adds execution and leverage risk. Maintain a HOLD and avoid adding above $300 absent higher normalized earnings or a material valuation reset.

What are TXN's latest audited financial fundamentals?

According to audited SEC EDGAR filings, Texas Instruments Incorporated reported total revenue of $17.68B (+13.0% YoY), Gross Margin of 57.0%, Free Cash Flow of $2.60B, and Net Debt of $10.82B.

What key risks and catalyst factors should investors monitor for TXN?
  • Q3 revenue rose 28% year over year while operating margin expanded 12.4 percentage points to 47.5%, demonstrating powerful fixed-cost leverage.
  • Trailing free cash flow reached $8.4 billion under TI's definition, but approximately $1.6 billion reflects direct CHIPS funding and investment-tax-credit cash benefits.
  • The $7.5 billion Silicon Labs transaction expands wireless connectivity but is priced near 9.6 times the target's 2025 revenue and depends on $450 million of annual synergies.